Pith Wave Signal

3 stories tagged #ASCO 2026

Newest Most read
  1. ASCO 2026: Weight Loss Intervention Significantly Improves Breast Cancer Quality of Life
    health

    ASCO 2026: Weight Loss Intervention Significantly Improves Breast Cancer Quality of Life

    BWEL trial results presented at ASCO 2026 show lifestyle-based weight loss interventions improve physical function and reduce fatigue in stage II-III breast cancer patients with elevated BMI.

    last wk. 1 min read
  2. Darolutamide Shows Cognitive Edge Over Enzalutamide in Prostate Cancer
    health

    Darolutamide Shows Cognitive Edge Over Enzalutamide in Prostate Cancer

    New data from the ARACOG trial shows darolutamide causes less cognitive decline than enzalutamide in prostate cancer patients.

    3w ago 1 min read
  3. TALAPRO-3 Shows PARP Inhibitor Combo Delays Prostate Cancer Progression
    health

    TALAPRO-3 Shows PARP Inhibitor Combo Delays Prostate Cancer Progression

    Phase 3 trial results presented at ASCO 2026 show talazoparib plus enzalutamide significantly improves radiographic progression-free survival in HRR-deficient metastatic castration-sensitive prostate cancer.

    3w ago 1 min read